Search

everythinglearnresearchcommunity

for

Search:↓

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Blocking IL-17a can improve age-related smell loss in mice.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Aged individuals heal wounds less effectively due to specific immune cell issues.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Skin bacteria can help wound healing by activating certain immune cells.

The summit aimed to speed up finding treatments for alopecia areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

New research is helping develop better treatments for alopecia areata.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Menstrual blood stem cell vesicles show promise for treating various medical conditions.

Targeting macrophages may improve wound healing.

Vitamin A affects hair loss and immune response in alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Nivolumab can cause hair loss as a rare side effect.